It is incomprehensible that Paxil is still on the market, almost 18 months after the FDA issued its warning about “early results of new studies for Paxil (paroxetine) suggesting that the drug increases the risk for birth defects, particularly heart defects, when women take it during the first three months of pregnancy.†Read the rest of this entry »